Furthermore, Tau—both total (t-tau) and phosphorylated (p-tau) forms—and β-amyloid (Aβ42) abnormalities, classically associated with Alzheimer’s disease (AD), are increasingly recognized in PD, particularly in those with non-motor symptoms [11]. The gene discussed is MAPT; the disease is Parkinson disease.